Shanghai Rongtai Health Technology Corporation Limited

XSSC:603579 Stock Report

Market Cap: CN¥2.5b

Shanghai Rongtai Health Technology Future Growth

Future criteria checks 1/6

Shanghai Rongtai Health Technology is forecast to grow earnings and revenue by 13.3% and 11.5% per annum respectively. EPS is expected to grow by 12.2% per annum. Return on equity is forecast to be 11.1% in 3 years.

Key information

13.3%

Earnings growth rate

12.2%

EPS growth rate

Leisure earnings growth24.4%
Revenue growth rate11.5%
Future return on equity11.1%
Analyst coverage

Low

Last updated30 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:603579 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,250264N/A3091
12/31/20251,969234N/A2782
12/31/20241,788209N/A2312
9/30/20241,72119360181N/A
6/30/20241,79020916137N/A
3/31/20241,87022884173N/A
12/31/20231,855203255344N/A
9/30/20231,741190151244N/A
6/30/20231,793183236302N/A
3/31/20231,826143223285N/A
12/31/20222,005164136237N/A
9/30/20222,310173276427N/A
6/30/20222,466182105248N/A
3/31/20222,65722698252N/A
12/31/20212,613236196338N/A
9/30/20212,480222136259N/A
6/30/20212,390234391542N/A
3/31/20212,215232421562N/A
12/31/20202,02119385276N/A
9/30/20202,09024658210N/A
6/30/20202,096258-95134N/A
3/31/20202,129267-15779N/A
12/31/20192,314296285446N/A
9/30/20192,167274221443N/A
6/30/20192,157245263359N/A
3/31/20192,204249222346N/A
12/31/20182,296249131261N/A
9/30/20182,398245176278N/A
6/30/20182,332246N/A307N/A
3/31/20182,155220N/A298N/A
12/31/20171,918216N/A281N/A
9/30/20171,709222N/A226N/A
6/30/20171,515217N/A220N/A
3/31/20171,370212N/A241N/A
12/31/20161,285207N/A176N/A
9/30/20161,192196N/A203N/A
12/31/20151,024143N/A215N/A
12/31/201472362N/A125N/A
12/31/201341126N/A77N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603579's forecast earnings growth (13.3% per year) is above the savings rate (2.8%).

Earnings vs Market: 603579's earnings (13.3% per year) are forecast to grow slower than the CN market (26.3% per year).

High Growth Earnings: 603579's earnings are forecast to grow, but not significantly.

Revenue vs Market: 603579's revenue (11.5% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 603579's revenue (11.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603579's Return on Equity is forecast to be low in 3 years time (11.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y